The drug that lost its viral edge but found a new life

Health · Published 19 October 2026 Swipe more like this →

In short: Amantadine was once a frontline defense against influenza, but widespread drug resistance rendered it nearly obsolete for antivirals. Yet, this same chemical structure became a vital tool for treating Parkinson's disease and traumatic brain injuries, revealing how one molecule can pivot between fighting viruses and rewiring human neurons.

Originally developed to inhibit the replication of influenza A virus by blocking its M2 proton channel, amantadine saw widespread use starting in 1966. However, its antiviral utility collapsed as resistance surged. During the flu season of 2008–2009, data from the CDC showed that every sample of pandemic flu from 2009 and seasonal H3N2 displayed resistance to amantadine-type adamantanes. Consequently, the WHO now recommends against using M2 inhibitors for influenza A. The drug's pivot occurred serendipitously in 1968 when its antiparkinsonian effects were discovered. Today, it is primarily used to treat levodopa-induced dyskinesia and rigidity associated with Parkinsonism. Its pharmacology is notably complex; rather than a single target, it acts as a sigma σ1 receptor agonist, a dopaminergic agent that increases dopamine release and blocks reuptake, a weak NMDA receptor antagonist, and a negative allosteric modulator of nicotinic acetylcholine receptors.

Beyond Parkinson's, amantadine is used in neuroplasticity-focused treatments for traumatic brain injury. To aid initial functional recovery, the American Academy of Neurology revised its 2018 protocols for disorders of consciousness (DoC), suggesting it for adults between 4 and 16 weeks post-injury. While its exact mechanism in these CNS disorders remains unclear, researchers believe it may stimulate dopamine or norepinephrine pathways to accelerate recovery during the critical window of neuroplasticity.

Note: Amantadine also presents unique diagnostic hurdles; it can inhibit the kidney's active-transport removal of creatinine by about 15%, potentially creating a false impression of mild kidney disease in healthy patients.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The sedative that caused a global medical catastrophe
• A 1940s antihistamine remains a medical paradox, balancing life-saving relief with severe tissue risks.
• Why antiviral drugs are fundamentally different from the antibiotics in your medicine cabinet
• Deadly nightshade's poison, atropine, became a nerve agent antidote
• How a blockbuster allergy drug changed the way pharmaceutical companies market their products
• Amiodarone is a potent heart medication that demands a careful, individualized approach to safety.
• If a therapy works, it usually stops being alternative
• An old antidepressant, amitriptyline found a second career treating pain
• In alopecia areata, the immune system breaks a hair follicle's special protection
• Why the blood pressure pill amlodipine can make ankles swell
• Aloe vera may not exist in the wild at all
• Amoxicillin is a staple for children, yet many ear infections don't need it

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics